FREMONT, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Abgenix, Inc.
(Nasdaq: ABGX) will announce financial results for the fourth quarter and full
year of 2005 on Tuesday, February 21, 2006, after the close of financial
markets. Following the announcement, Abgenix will host a conference call at
1:30 p.m. Pacific Time that afternoon to review the company's financial
results.
The live and archived webcasts of the conference call will be available on
the Abgenix website, http://www.abgenix.com. To participate in the conference call,
please dial 800-591-6944 fifteen minutes before the conference begins.
International callers should dial 617-614-4910. The pass code is 82136361. A
telephonic replay of the call will be available by dialing 888-286-8010.
International callers should dial 617-801-6888. The replay participant code is
66896648.
About Abgenix
Abgenix is a biopharmaceutical company focused on the discovery,
development and manufacturing of human therapeutic antibodies. The company's
antibody development platform includes a leading technology and
state-of-the-art manufacturing capabilities that enable the rapid generation,
selection and production of high affinity, fully human antibody product
candidates to a variety of disease targets. Abgenix leverages its leadership
position in human antibody technology to build a diversified product portfolio
through the establishment of collaborations with multiple pharmaceutical and
biotechnology companies. For more information on Abgenix, visit the company's
website at http://www.abgenix.com.
SOURCE Abgenix, Inc.
 back to top
Related links:
http://www.abgenix.com
CONTACT:
Greg Mann, Director of Corporate
Communications & Investor Relations of Abgenix, +1-510-284-6566
|
